The weekly litigation news digest is live. Subscribe now

IP Verse

Neuroderm competitive analysis

Loading summary...

Latest patents of Neuroderm opposed by its competitors

Explore Neuroderm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 27, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2432454
Mar 1, 2017Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors1

Latest PTAB cases involving Neuroderm

Discover the latest PTAB cases involving Neuroderm, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 26, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Neuroderm

PGR2022-00040May 12, 2022NEURODERMABBVIEFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Neuroderm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 27, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NEURODERM - 11 -
ABBVIE109 - 1
TEVA PHARMACEUTICALS20916 - 12